BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 37820678)

  • 1. Impact of miR-519d on the Biological Activity of Non-Small Cell Lung Cancer Cells and Its Mechanism.
    Wang K; Zhao X; Liu S; Xu S
    Altern Ther Health Med; 2024 Jan; 30(1):466-471. PubMed ID: 37820678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells.
    Ye Y; Zhao L; Li Q; Xi C; Li Y; Li Z
    Thorac Cancer; 2020 Aug; 11(8):2196-2208. PubMed ID: 32602212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-519d-3p enhances the sensitivity of non-small-cell lung cancer to tyrosine kinase inhibitors.
    Zhen Q; Zhang Y; Gao L; Wang R; Chu W; Zhao X; Li Z; Li H; Zhang B; Lv B; Liu J
    Mamm Genome; 2021 Dec; 32(6):508-516. PubMed ID: 34586488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells.
    Qiu HB; Yang K; Yu HY; Liu M
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8391-8402. PubMed ID: 31646569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA HOTAIRM1 knockdown inhibits cell glycolysis metabolism and tumor progression by miR-498/ABCE1 axis in non-small cell lung cancer.
    Chen D; Li Y; Wang Y; Xu J
    Genes Genomics; 2021 Feb; 43(2):183-194. PubMed ID: 33537917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CiRS-7 targeting miR-7 modulates the progression of non-small cell lung cancer in a manner dependent on NF-κB signalling.
    Su C; Han Y; Zhang H; Li Y; Yi L; Wang X; Zhou S; Yu D; Song X; Xiao N; Cao X; Liu Z
    J Cell Mol Med; 2018 Jun; 22(6):3097-3107. PubMed ID: 29532994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Noncoding RNA LINC01426 Sequesters microRNA-519d-5p to Promote Non-Small Cell Lung Cancer Progression by Increasing ETS1 Expression.
    Dai J; Wang B; Zhao Y; Zuo X; Cui H; Chen X; Liu X
    Cancer Manag Res; 2020; 12():12697-12708. PubMed ID: 33335425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LINC00839/miR-519d-3p/JMJD6 axis modulated cell viability, apoptosis, migration and invasiveness of lung cancer cells.
    Yu X; Jiang Y; Hu X; Ge X
    Folia Histochem Cytobiol; 2021; 59(4):271-281. PubMed ID: 34734406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA PRNCR1 modulates non-small cell lung cancer cell proliferation, apoptosis, migration, invasion, and EMT through PRNCR1/miR-126-5p/MTDH axis.
    Guo R; Hu T; Liu Y; He Y; Cao Y
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 31912882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The microRNA-520a-3p inhibits invasion and metastasis by targeting NF-kappaB signaling pathway in non-small cell lung cancer.
    Fang X; Shi H; Sun F
    Clin Transl Oncol; 2022 Aug; 24(8):1569-1579. PubMed ID: 35247196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Significance and Tumor-Suppressive Function of miR-516b in Nonsmall Cell Lung Cancer.
    Zhu J; Zhang Y; Yang X; Jin L
    Cancer Biother Radiopharm; 2017 May; 32(4):115-123. PubMed ID: 28514208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of microRNA-513b on cell proliferation, apoptosis, invasion, and migration by targeting HMGB3 through regulation of mTOR signaling pathway in non-small-cell lung cancer.
    Wang J; Sheng Z; Cai Y
    J Cell Physiol; 2019 Jul; 234(7):10934-10941. PubMed ID: 30623409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-411-5p acts as a tumor suppressor in non-small cell lung cancer through targeting PUM1.
    Xia LH; Yan QH; Sun QD; Gao YP
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5546-5553. PubMed ID: 30229827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-519d-3p Overexpression Inhibits P38 and PI3K/AKT Pathway via Targeting VEGFA to Attenuate the Malignant Biological Behavior of Non-Small Cell Lung Cancer.
    Zhang G; Hu Y; Yuan W; Qiu H; Yu H; Du J
    Onco Targets Ther; 2020; 13():10257-10266. PubMed ID: 33116606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA SNHG1 influences cell proliferation, migration, invasion, and apoptosis of non-small cell lung cancer cells via the miR-361-3p/FRAT1 axis.
    Li X; Zheng H
    Thorac Cancer; 2020 Feb; 11(2):295-304. PubMed ID: 31788970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA SNHG15 accelerates the progression of non-small cell lung cancer by absorbing miR-211-3p.
    Ma XR; Xu YL; Qian J; Wang Y
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1536-1544. PubMed ID: 30840276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of miR-519d in lung adenocarcinoma inhibits cell proliferation and invasion via the association of eIF4H.
    Bai Y; Lu C; Zhang G; Hou Y; Guo Y; Zhou H; Ma X; Zhao G
    Tumour Biol; 2017 Mar; 39(3):1010428317694566. PubMed ID: 28351305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-519d targets HER3 and can be used as a potential serum biomarker for non-small cell lung cancer.
    Wang A; Zhang H; Wang J; Zhang S; Xu Z
    Aging (Albany NY); 2020 Mar; 12(6):4866-4878. PubMed ID: 32170048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.